A detailed history of Israel Englander (Millennium Management LLC) transactions in Veracyte, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 335,509 shares of VCYT stock, worth $13.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
335,509
Previous 64,231 422.35%
Holding current value
$13.1 Million
Previous $1.39 Million 720.78%
% of portfolio
0.01%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$21.0 - $35.25 $5.7 Million - $9.56 Million
271,278 Added 422.35%
335,509 $11.4 Million
Q2 2024

Aug 14, 2024

BUY
$18.86 - $23.55 $353,851 - $441,845
18,762 Added 41.26%
64,231 $1.39 Million
Q1 2024

May 15, 2024

BUY
$21.0 - $29.1 $521,661 - $722,873
24,841 Added 120.42%
45,469 $1.01 Million
Q4 2023

Feb 14, 2024

SELL
$19.72 - $28.68 $151,567 - $220,434
-7,686 Reduced 27.15%
20,628 $567,000
Q2 2023

Aug 14, 2023

SELL
$20.96 - $26.99 $2.52 Million - $3.25 Million
-120,399 Reduced 80.96%
28,314 $721,000
Q1 2023

May 15, 2023

BUY
$20.58 - $27.89 $890,146 - $1.21 Million
43,253 Added 41.01%
148,713 $3.32 Million
Q4 2022

Feb 14, 2023

BUY
$15.31 - $29.94 $1.45 Million - $2.84 Million
94,711 Added 881.11%
105,460 $2.5 Million
Q3 2022

Nov 14, 2022

BUY
$16.58 - $27.9 $178,218 - $299,897
10,749 New
10,749 $178,000
Q2 2022

Aug 15, 2022

SELL
$15.45 - $29.52 $2.83 Million - $5.4 Million
-183,019 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$21.94 - $42.51 $2.51 Million - $4.86 Million
114,380 Added 166.64%
183,019 $5.05 Million
Q4 2021

Feb 14, 2022

BUY
$36.09 - $53.79 $2.48 Million - $3.69 Million
68,639 New
68,639 $2.83 Million
Q3 2021

Nov 15, 2021

SELL
$35.62 - $52.97 $7.62 Million - $11.3 Million
-214,023 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$32.94 - $56.62 $2.32 Million - $3.99 Million
70,453 Added 49.07%
214,023 $8.56 Million
Q1 2021

May 17, 2021

SELL
$44.47 - $81.38 $5.39 Million - $9.87 Million
-121,229 Reduced 45.78%
143,570 $7.72 Million
Q4 2020

Feb 16, 2021

BUY
$32.49 - $61.88 $4.45 Million - $8.48 Million
136,991 Added 107.18%
264,799 $13 Million
Q3 2020

Nov 16, 2020

BUY
$26.73 - $35.67 $3.42 Million - $4.56 Million
127,808 New
127,808 $4.15 Million
Q2 2020

Aug 14, 2020

SELL
$19.49 - $28.11 $1.93 Million - $2.79 Million
-99,230 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$16.13 - $30.17 $1.6 Million - $2.99 Million
99,230 New
99,230 $2.41 Million
Q4 2019

Feb 14, 2020

SELL
$20.78 - $29.99 $7.54 Million - $10.9 Million
-363,025 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$23.87 - $30.93 $4.59 Million - $5.95 Million
-192,398 Reduced 34.64%
363,025 $8.71 Million
Q2 2019

Aug 15, 2019

SELL
$22.1 - $28.56 $32.7 Million - $42.3 Million
-1,480,345 Reduced 72.72%
555,423 $15.8 Million
Q2 2019

Aug 14, 2019

BUY
$22.1 - $28.56 $26.9 Million - $34.7 Million
1,216,541 Added 148.5%
2,035,768 $15.5 Million
Q1 2019

May 14, 2019

SELL
$12.0 - $25.76 $7.19 Million - $15.4 Million
-599,059 Reduced 42.24%
819,227 $20.5 Million
Q4 2018

Feb 14, 2019

BUY
$9.15 - $14.85 $5.81 Million - $9.42 Million
634,597 Added 80.98%
1,418,286 $17.8 Million
Q3 2018

Nov 14, 2018

SELL
$9.55 - $12.64 $746,303 - $987,778
-78,147 Reduced 9.07%
783,689 $7.48 Million
Q2 2018

Aug 14, 2018

BUY
$5.39 - $9.66 $733,557 - $1.31 Million
136,096 Added 18.75%
861,836 $8.05 Million
Q1 2018

May 15, 2018

SELL
$5.44 - $6.97 $299,363 - $383,559
-55,030 Reduced 7.05%
725,740 $4.04 Million
Q4 2017

Feb 14, 2018

BUY
$6.05 - $9.37 $139,688 - $216,343
23,089 Added 3.05%
780,770 $5.1 Million
Q3 2017

Nov 14, 2017

BUY
$7.81 - $8.77 $5.92 Million - $6.64 Million
757,681
757,681 $6.65 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.79B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.